A detailed history of Acuitas Investments, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Acuitas Investments, LLC holds 132,502 shares of KOD stock, worth $352,455. This represents 0.18% of its overall portfolio holdings.

Number of Shares
132,502
Previous 131,803 0.53%
Holding current value
$352,455
Previous $693,000 55.12%
% of portfolio
0.18%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$2.29 - $4.48 $1,600 - $3,131
699 Added 0.53%
132,502 $311,000
Q1 2024

May 10, 2024

SELL
$3.01 - $7.45 $307,889 - $762,053
-102,289 Reduced 43.7%
131,803 $693,000
Q4 2023

Feb 02, 2024

BUY
$1.4 - $3.24 $121,860 - $282,019
87,043 Added 59.19%
234,092 $711,000
Q3 2023

Oct 27, 2023

BUY
$1.8 - $7.49 $264,688 - $1.1 Million
147,049 New
147,049 $264,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $138M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Acuitas Investments, LLC Portfolio

Follow Acuitas Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuitas Investments, LLC with notifications on news.